Genetic Technologies (ASX:GTG) Other Current Payables: A$0.19 Mil (As of Jun. 2024)


What is Genetic Technologies Other Current Payables?

Genetic Technologies ASX:GTG Other Current Payables is A$0.19 Mil as of Jun. 2024.

Genetic Technologies's Other Current Payables for the quarter that ended in Jun. 2024 was A$0.19 Mil.

Genetic Technologies's quarterly Other Current Payables stayed the same from Dec. 2023 (A$0.00 Mil) to Mar. 2024 (A$0.00 Mil) but then increased from Mar. 2024 (A$0.00 Mil) to Jun. 2024 (A$0.19 Mil).

Genetic Technologies's annual Other Current Payables declined from Jun. 2022 (A$0.95 Mil) to Jun. 2023 (A$0.16 Mil) but then increased from Jun. 2023 (A$0.16 Mil) to Jun. 2024 (A$0.19 Mil).

Genetic Technologies Other Current Payables Related Terms

Genetic Technologies Other Current Payables Historical Data

* Premium members only.

The historical data trend for Genetic Technologies's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genetic Technologies Other Current Payables Chart

Genetic Technologies Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.01 0.95 0.16 0.19

Genetic Technologies Quarterly Data
Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.19 0.00

Genetic Technologies Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of A$0.19 Mil mean?
Genetic Technologies (ASX:GTG) has a Other Current Payables of A$0.19 Mil as of Jun. 2024. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Genetic Technologies and its competitors.
Is Genetic Technologies' Other Current Payables too high?
Genetic Technologies' current Other Current Payables is A$0.19 Mil.
How does Genetic Technologies' Other Current Payables compare to LDDD and NOTV?
Genetic Technologies' Other Current Payables of A$0.19 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Diagnostics & Research company?
A good Other Current Payables depends on the Medical Diagnostics & Research industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Genetic Technologies and its competitors. Genetic Technologies's current Other Current Payables is A$0.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genetic Technologies stock overvalued right now?
Genetic Technologies (ASX:GTG) has a current Other Current Payables of A$0.19 Mil. The current Other Current Payables is A$0.19 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Genetic Technologies (ASX:GTG), the current Other Current Payables is A$0.19 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genetic Technologies Business Description

Address 60-66 Hanover Street, Fitzroy, Melbourne, VIC, AUS, 3065
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.